Gyfts is in early access.Join the waitlist
Skip to main content
Ian Henderson
Gyfts editorial contributor

Ian Henderson

Advisor

PhD, BSc (Hons), PGCHE, FRSB

MicrobiologyBacterial Cell BiologyHost–Pathogen InteractionsProtein SecretionInfectious DiseaseMolecular BioscienceScientific Evidence Appraisal

82 pages reviewed on Gyfts

Ian advises Gyfts on scientific rigour, evidence context, and responsible health-adjacent discovery. He is Executive Director of the Institute for Molecular Bioscience at The University of Queensland and Professor of Microbial Biology, with a research career focused on bacterial cell surfaces, host–pathogen interactions, and infectious disease. His work spans over 150 peer-reviewed papers cited more than 15,000 times (h-index 62).

Credentials & Background

Education

BSc (Hons)

University College Dublin

PhD

Trinity College Dublin

PGCHE (Teaching & Learning in Higher Education)

University of Birmingham

Experience

Executive Director, Institute for Molecular Bioscience

The University of Queensland

Present

Leads the IMB; Professor of Microbial Biology researching bacterial cell surfaces, protein secretion, and host–pathogen interactions.

Deputy Director (Research), Institute for Molecular Bioscience

The University of Queensland

Prior

Research leadership at the IMB.

Director, Institute of Microbiology and Infection

University of Birmingham

2015 — 2018

Directed the Institute of Microbiology and Infection.

Scientific Advisor

Gyfts

Present

Advises Gyfts on scientific rigour, evidence context, and responsible health-adjacent discovery.

Affiliations

Royal Society of Biology

Fellow (FRSB)

The University of Queensland

Executive Director, Institute for Molecular Bioscience

Conditions Reviewed

82 condition pages reviewed for clinical accuracy

Publications

Type V protein secretion pathway: the autotransporter story

Microbiology and Molecular Biology Reviews

2004

The pangenome structure of Escherichia coli: comparative genomic analysis of commensal and pathogenic isolates

Journal of Bacteriology

2008

Alternatives to antibiotics — a pipeline portfolio review

The Lancet Infectious Diseases

2016

Conflict of Interest Disclosure

This reviewer reports no financial relationships with supplement manufacturers, therapy providers, or entities discussed in Gyfts content. Gyfts reviewers are independent and do not receive compensation based on practitioner listings or modality promotion.

Profile last updated 4 March 2026